Micro & Immunology · single question

A patient presents with an NSAIDs prescription that has recently started causing a reaction. The reaction involves mast cell activation. Which hypersensitivity type is this?

  1. Type III — immune complex
  2. Type I — IgE mediated
  3. Type IV — cell mediated
  4. Type II — cytotoxic
Show answer and explanation

Correct answer: B. Type I — IgE mediated

Type I hypersensitivity involves mast cells and IgE. However, NSAID reactions are often pseudo-allergic — they activate mast cells through a non-IgE mechanism (COX-1 inhibition diverts arachidonic acid to leukotriene production, which directly activates mast cells). On INBDE, if mast cells are mentioned with an immediate reaction, select Type I. The key differentiator: Type I = immediate, IgE-mast cell; Type IV = delayed, T-cell mediated.
  • A. ❌ Type III is immune complex deposition — does not primarily involve mast cells.
  • B. ✅ CORRECT – Mast cell-mediated reactions correspond to Type I hypersensitivity (immediate, IgE-mast cell pathway). NSAIDs can trigger mast cell activation directly.
  • C. ❌ Type IV is cell-mediated (T-lymphocyte) delayed hypersensitivity — mast cells are not the primary effector cells.
  • D. ❌ Type II is antibody-mediated cytotoxicity against cell surface antigens — does not involve mast cells.

Practice Micro & Immunology questions Micro & Immunology study notes

More Micro & Immunology practice questions